DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
用于癌症诊断和治疗的 DNA 连接树枝状聚合物纳米粒子系统
基本信息
- 批准号:7279187
- 负责人:
- 金额:$ 47.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-29 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAminesAnimal ModelAnimalsAntibodiesAntineoplastic AgentsAvidityBindingBiodistributionBiologicalBiological SciencesBiologyCaliberCalorimetryCancer InterventionCell DeathChelating AgentsChemotherapy-Oncologic ProcedureComplementary DNAComplexComputer AnalysisCouplingCultured CellsCustomDendrimersDevelopmentDevicesDiagnosisDiagnostic ImagingDigestionDoxorubicinEffectivenessFiber OpticsFluorescent DyesFolic AcidFundingGadoliniumGeneticHairHeatingHigh Pressure Liquid ChromatographyImageIn VitroIndividualInstitute of Medicine (U.S.)KidneyLinkLinker-OligonucleotideMalignant NeoplasmsMedicineMethodsMethotrexateMichiganModelingModificationNMR SpectroscopyNanotechnologyNauseaOligonucleotidesOpticsPaclitaxelPatientsPharmaceutical PreparationsPhysiciansPhysicsPhysiologic pulsePolymersPulse takingRGD (sequence)RadiolabeledResearch PersonnelScienceSeriesSignal TransductionSiteSolutionsSpecificityStagingStructureSystemTechniquesTechnologyTemperatureTestingTherapeuticToyTranscendUniversitiesWorkbasecancer cellcancer diagnosiscancer therapycombinatorialconceptcytotoxicitydesigndesirefunctional groupin vivonanodevicenanometernanoparticlenanoscalenovelnucleaseprogramsradiotracerscaffoldtooltumortwo-photon
项目摘要
DESCRIPTION (provided by applicant):
Targeted dendrimer-based nanodevices have shown excellent promise in both in vitro cell culture and in vivo animal studies as cancer therapeutics. However, each device must be custom synthesized for a particular set of targeting molecules, imaging agents, and desired therapeutics. We propose a unique solution to this limitation by developing single function dendrimer modules linked by complementary oligonucleotides. This allows targeting, imaging, and therapeutic dendrimers to be combined into multifunctional therapeutics simply by heating mixtures of these agents above the annealing temperature of the oligonucleotide duplex. The project will consist of five specific aims. Specific Aim 1 will involve the design and synthesis of complementary oligonucleotides conjugated to poly(amido)amine dendrimers or dendrons to achieve the desired structural topologies. The ability to construct complex devices will be assessed using well-defined targeting molecules (folic acid, her2 antibodies and RGD peptides), drugs (methotrexate, Taxol, cis-platin and doxorubicin), imaging agents (Gadolinium chelators and fluorescent dyes). Specific Aim 2 will characterize the self-assembled nanodevices using techniques including PAGE, HPLC, CE, Mass Spectroscopy, NMR, AFM, and NSOM. Specific Aim 3 involves testing the DNA-linked nanodevices for binding and internalization in vitro; the avidity and specificity of binding will be examined using CD, differential calorimetry and Biacore analyses. Devices carrying therapeutics will be tested for effectiveness at inducing cell death, and all devices will also be tested for inherent cytotoxicity. Specific Aim 4 employs animal models to assess the effectiveness of the dendrimer linked therapeutics to treat tumors in vivo. In addition, the biodistribution of the therapeutics will be assessed using radiolabeled material and a novel fiber optic probe that uses two-photon excitation with femto-second pulses. Finally, under Specific Aim 5 we will work with the NCI nanoparticle characterization lab in Frederick to make the materials developed in this program available to other investigators. This platform has the potential to revolutionize cancer therapeutics and facilitate "personalized medicine."
Lay description: We are designing a method and the tools for developing targeted cancer drugs that can be tailored to the needs of an individual patient. The physician can select various components and the components are then linked together like "tinker toys" to make a personalized medicine. This medicine would selectively target only the cancer, thereby avoiding the nausea, hair loss and illness caused by regular cancer chemotherapy.
描述(由申请人提供):
靶向的基于树枝状聚合物的纳米器件已经在体外细胞培养和体内动物研究中显示出作为癌症治疗剂的良好前景。然而,每个装置必须针对特定的靶向分子、成像剂和所需治疗剂的集合定制合成。我们提出了一个独特的解决方案,通过开发由互补寡核苷酸连接的单功能树枝状聚合物模块来解决这一限制。这允许靶向、成像和治疗性树枝状聚合物简单地通过将这些试剂的混合物加热到高于寡核苷酸双链体的退火温度而组合成多功能治疗剂。该项目将包括五个具体目标。具体目标1将涉及与聚(酰胺基)胺树枝状聚合物或树枝状分子缀合的互补寡核苷酸的设计和合成,以实现所需的结构拓扑。将使用明确定义的靶向分子(叶酸、her 2抗体和RGD肽)、药物(甲氨蝶呤、紫杉醇、顺铂和多柔比星)、成像剂(钆螯合剂和荧光染料)评估构建复杂器械的能力。具体目标2将使用包括PAGE、HPLC、CE、质谱、NMR、AFM和NSOM在内的技术来表征自组装纳米器件。具体目标3涉及测试DNA连接的纳米器件在体外的结合和内化;结合的亲合力和特异性将使用CD、差示量热法和Biacore分析来检查。将测试携带治疗剂的器械诱导细胞死亡的有效性,还将测试所有器械的固有细胞毒性。具体目标4采用动物模型来评估树状聚合物连接的治疗剂在体内治疗肿瘤的有效性。此外,将使用放射性标记材料和使用飞秒脉冲双光子激发的新型光纤探针评估治疗剂的生物分布。最后,在具体目标5下,我们将与弗雷德里克的NCI纳米颗粒表征实验室合作,使该计划中开发的材料可供其他研究人员使用。这个平台有可能彻底改变癌症治疗方法,促进“个性化医疗”。"
铺设说明:我们正在设计一种方法和工具,用于开发可以根据个体患者需求量身定制的靶向癌症药物。医生可以选择各种成分,然后将这些成分像“修补玩具”一样连接在一起,以制作个性化的药物。这种药物将选择性地只针对癌症,从而避免常规癌症化疗引起的恶心,脱发和疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES R. BAKER其他文献
JAMES R. BAKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES R. BAKER', 18)}}的其他基金
Nanoemulsion-based vaccine for chronic hepatitis B virus
慢性乙型肝炎病毒纳米乳疫苗
- 批准号:
7806254 - 财政年份:2010
- 资助金额:
$ 47.19万 - 项目类别:
Photonic Crystal Fiber Probe Fluorescence Biosensing
光子晶体光纤探针荧光生物传感
- 批准号:
7274819 - 财政年份:2005
- 资助金额:
$ 47.19万 - 项目类别:
DNA-linked dendrimer nanoparticle systems for diagnosis
用于诊断的 DNA 连接树枝状聚合物纳米颗粒系统
- 批准号:
7050850 - 财政年份:2005
- 资助金额:
$ 47.19万 - 项目类别:
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
用于癌症诊断和治疗的 DNA 连接树枝状聚合物纳米粒子系统
- 批准号:
7475097 - 财政年份:2005
- 资助金额:
$ 47.19万 - 项目类别:
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
用于癌症诊断和治疗的 DNA 连接树枝状聚合物纳米粒子系统
- 批准号:
7669087 - 财政年份:2005
- 资助金额:
$ 47.19万 - 项目类别:
DNA-linked dendrimer nanoparticle systems for diagnosis
用于诊断的 DNA 连接树枝状聚合物纳米颗粒系统
- 批准号:
7127295 - 财政年份:2005
- 资助金额:
$ 47.19万 - 项目类别:
Photonic Crystal Fiber Probe Fluorescence Biosensing
光子晶体光纤探针荧光生物传感
- 批准号:
7123836 - 财政年份:2005
- 资助金额:
$ 47.19万 - 项目类别:
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
用于癌症诊断和治疗的 DNA 连接树枝状聚合物纳米粒子系统
- 批准号:
7771452 - 财政年份:2005
- 资助金额:
$ 47.19万 - 项目类别:
DNA-linked dendrimer nanoparticle systems for cancer diagnosis and treatment
用于癌症诊断和治疗的 DNA 连接树枝状聚合物纳米粒子系统
- 批准号:
7925116 - 财政年份:2005
- 资助金额:
$ 47.19万 - 项目类别:
相似海外基金
More sustainable biocatalytic imine reductions to chiral amines with hydrogen-driven NADPH recycling operated in batch and continuous flow
通过批量和连续流操作的氢驱动 NADPH 回收,更可持续地生物催化亚胺还原为手性胺
- 批准号:
2889869 - 财政年份:2023
- 资助金额:
$ 47.19万 - 项目类别:
Studentship
Organoborane-catalysed approaches to biologically active amines
有机硼烷催化制备生物活性胺的方法
- 批准号:
EP/Y00146X/1 - 财政年份:2023
- 资助金额:
$ 47.19万 - 项目类别:
Research Grant
Transforming Amines into Complex Polycyclic Molecules and Bioactive Natural Products
将胺转化为复杂的多环分子和生物活性天然产物
- 批准号:
2247651 - 财政年份:2023
- 资助金额:
$ 47.19万 - 项目类别:
Standard Grant
Ti-catalyzed cascading hydroaminoalkylation as a route to complex functionalized amines
Ti 催化级联氢氨基烷基化作为制备复杂官能化胺的途径
- 批准号:
10750347 - 财政年份:2023
- 资助金额:
$ 47.19万 - 项目类别:
New Photocatalytic C-C Bond-Forming Reactivity of Unprotected Primary Amines
未受保护伯胺的新光催化 C-C 键形成反应
- 批准号:
EP/X026566/1 - 财政年份:2023
- 资助金额:
$ 47.19万 - 项目类别:
Research Grant
Nickel Cross-Coupling Cascades with α-Heteroatom Radicals to Prepare Sterically Hindered Alcohols and Amines
镍与α-杂原子自由基交叉偶联级联制备位阻醇和胺
- 批准号:
10604535 - 财政年份:2023
- 资助金额:
$ 47.19万 - 项目类别:
Towards a better understanding of the effect of the pentafluorosulfanyl group on the lipophilicity and acid/base properties of alcohols and amines
更好地了解五氟硫基对醇和胺的亲脂性和酸/碱性质的影响
- 批准号:
571856-2021 - 财政年份:2022
- 资助金额:
$ 47.19万 - 项目类别:
Alliance Grants
Development of Strategies for the Enantioselective Synthesis of Heterocycles and Acyclic Amines
杂环和无环胺对映选择性合成策略的发展
- 批准号:
10656344 - 财政年份:2022
- 资助金额:
$ 47.19万 - 项目类别:
Pd-Catalyzed C(sp3)-H Functionalizations Directed by Free Alcohols and Boc-Protected Amines
由游离醇和 Boc 保护的胺引导的 Pd 催化 C(sp3)-H 官能化
- 批准号:
10606508 - 财政年份:2022
- 资助金额:
$ 47.19万 - 项目类别: